Uracil CAS 66-22-8: A Versatile Pharmaceutical Intermediate
Unlock the potential of Uracil for advanced drug synthesis and critical biochemical applications.
Get a Quote & SampleProduct Core Value

Uracil
Uracil (CAS 66-22-8) is a foundational pyrimidine nucleobase crucial for RNA, playing a key role in genetic information transfer. Its high purity makes it an ideal pharmaceutical intermediate for a wide array of applications, from life-saving anticancer drugs to specialized agricultural chemicals.
- Discover the extensive uses of Uracil in RNA structure and its fundamental role in cellular biochemistry.
- Explore Uracil as a key intermediate for the synthesis of vital anticancer drugs like 5-fluorouracil.
- Learn about Uracil's application in pesticide manufacturing, particularly in inhibiting photosynthesis.
- Understand the various Uracil preparation methods and its significance in drug delivery systems.
Key Advantages
Unmatched Purity for Pharmaceutical Use
Achieve superior results in your drug synthesis processes by utilizing high purity Uracil powder, ensuring reliable outcomes.
Broad Application Spectrum
From pharmaceuticals to agricultural chemicals, Uracil's versatility makes it indispensable across multiple industries.
Essential for Biochemical Pathways
Leverage Uracil's critical function in carbohydrate metabolism and as a coenzyme to enhance your biochemical research.
Key Applications
Pharmaceutical Synthesis
Uracil is a primary building block for synthesizing various pharmaceuticals, including crucial anticancer agents, making it a cornerstone for drug development.
Biochemical Research
Its role in RNA and carbohydrate metabolism makes Uracil an indispensable tool for understanding and advancing biochemical processes and life sciences research.
Agrochemical Development
Uracil derivatives are employed in creating effective pesticides, particularly those that target and inhibit photosynthesis in weeds.
Drug Delivery Systems
The compound's properties lend themselves to innovative drug delivery applications, enhancing therapeutic efficacy and patient outcomes.